For many businesses, being public is no longer worth the hassle. — Bloomberg
SOME of Japan’s most notable companies are feeling somewhat listless about being listed.
That might be the reason for the US$5bil take-private offer for Taisho Pharmaceutical Co, the largest management buyout in Japanese history, announced last week.
